Recombinant human interferon α-2b (rh IFNα-2b) therapy for steroid resistant idiopathic thrombocytopenic purpura (ITP)

American Journal of Hematology

Volumn 51, Issue 1, 1996, Pages 37-44

  Fujimura, Kingo ^a   Takafuta, Toshiro ^a   Kuriya, Shin Ichiro ^b   Abe, Tsukasa ^c   Akatsuka, Jun Ichi ^d   Yasunaga, Kojiro ^e   Uchida, Tatsumi ^f   Kawakita, Makoto ^g   Kitamura, Kiyoshi ^h   Nomura, Takeo ⁱ   Kuramoto, Atsushi ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

^b IWATE MEDICAL UNIVERSITY   (Japan)

^c UNIVERSITY OF TSUKUBA   (Japan)

^d JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^e School of Medicine   (Japan)

^f TAKAMATSU RED CROSS HOSPITAL   (Japan)

^g KUMAMOTO UNIV SCHOOL OF MEDICINE   (Japan)

^h UNIVERSITY OF TOKYO   (Japan)

ⁱ NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

Interferon 2b treatment; Steroid resistant ITP

Indexed keywords

CORTICOSTEROID; DANAZOL; IMMUNOGLOBULIN; RECOMBINANT ALPHA2B INTERFERON;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; FATIGUE; FEMALE; FEVER; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; THROMBOCYTE COUNT; THROMBOCYTOPENIC PURPURA;

ADOLESCENT; ADRENAL CORTEX HORMONES; ADULT; AGED; BIOLOGICAL RESPONSE MODIFIERS; CHILD; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; DRUG ADMINISTRATION SCHEDULE; DRUG RESISTANCE; FEMALE; HUMANS; INFANT; INTERFERON ALFA-2B; MALE; MIDDLE AGED; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC; SPLENECTOMY; TREATMENT OUTCOME;

EID: 9044233261     PISSN: 03618609     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-8652(199601)51:1<37::AID-AJH7>3.0.CO;2-8     Document Type: Article

References (18)

1. Berchtold P, McMillan R: Therapy of chronic idiopathic thrombocytopenic purpura in adults. Blood 74:2309-2317, 1989.
2. Proctor SJ, Jackson G, Carey P, Stark A, Finney R, Saunders P, Summerfield G, Maharaj D, Youan A Improvement of platelet counts in steroid-unresponsive idiopathic immune thrombocytopenic purpura after short course therapy with recombinant α-2b interferon Blood 74:1894-1897, 1989.
3. Bellucci S, Bordessoule D, Coiffier B, Tabah I: Interferon alfa-2b therapy in adult chronic thrombocytopenic purpura (ITP). Br J Haematol 73:578, 1989.
4. Hurtado R, Pita L, Karpovitch XL, Cardenas R, Piedras J, Carrillo S, Labaradini J: Recombinant interferon alfa-2b in refractory idiopathic immune thrombocytopenia. Blood 75:1744-1745, 1990.
5. Chistolini A, Mazzucconi MG, Dragoni F, De Sancus V, Mandelli F: Recombinant alpha 2b interferon in the treatment of refractory autoimmune thrombocytopenic purpura. Br J Haematol 80:416-417, 1992.
6. Facon T, Caulier MT, Fenaux P, Wibaut B, Cappelaere A, Quiquandon I, Banters F: Interferon alpha-2b therapy in refractory adult chronic thrmobocytopenic purpura. Br J Haematol 78:464-465, 1991.
7. Ellis ME, Neal KR, Leen CLS Alfa-2b recombinant interferon in HIV associated thrombocytopenia Br Med J 295:1519, 1987.
8. Lever AML, Brook MG, Yap I, Thomas HC: Treatment of thrombocytopenia with alfa interferon. Br Med J 295:1519-1520, 1987
9. Proctor SJ, Jackson G, Carey P, Stark A. Short-course alpha-interferon therapy in severe unresponsive immune thrombocytopenic purpura. Lancet 1:947, 1988.
10. Kumakura S, Ishikura H, Tsumura H, Endo J, Tsunematsu T: A favourable effect of long-term alfa-interferon therapy in refractory idiopathic thrombocytopenic purpura. Br J Haematol 85:805-807, 1993
11. Conlon KC, Urba WJ, Smith JW, Steis RG, Longo DL, Clark JW: Exacerbation of symptoms of autoimmune disease in patients receiving alpha interferon therapy Cancer 65:2237-2242, 1990.
12. Fentiman IS, Balkwill FR, Thomas BS, Russell MJ, Todd I, Bottazzo GF: An autoimmune aetiology for hypothyroidism following interferon therapy for breast cancer. Eur J Cancer Clin Oncol 24:1299-1303, 1988.
13. Mayet WJ, Hess G, Gerken G, Rossol S, Voth R, Manns M, Zum Buchenfelde KHM. Treatment of chronic type B hepatitis with recombinant interferon induces autoantibodies not specific for autoimmune chronic hepatitis. Hepatology 10:24-28, 1989.
14. Burman P, Karlsson FA, Oberg K, Alm G: Autoimmune thyroid disease in interferon-treated patients. Lancet 2:100-101, 1985.
15. Hoofnagle JH: Thrombocytopenia during interferon alfa therapy. JAMA 266:849, 1991.
16. Matthey F, Ardeman S, Jones L, Newland AC: Bleeding in immune thrombocytopenic purpura after alpha-interferon. Lancet 1:471-472, 1990.
17. Benjamin S, Dodsworth H: Severe bleeding associated with worsening thrombocytopenia following alpha interferon therapy for autoimmune thrombocytopenic purpura. Clin Lab Haematol 13:315-317, 1991.
18. Northfelt DW, Kaplan LD, Abrams DI: Continuous, low-dose therapy with interferon for human immunodeficiency virus (HIV)-related immune thrombocytopenic purpura Am J Hematol 38:236-239, 1991.